Biomedical subjects

S Matuska

Publications and source records attributed to S Matuska.

3 recordsLinked to original sources

PubMed2003

Bilateral Acanthamoeba keratitis with late recurrence of the infection in a corneal graft: a case report.

PURPOSE: To report a case of bilateral Acanthamoeba keratitis with late, atypical recurrence after penetrating keratoplasty a chaud. METHODS: A 23-year-old contact lens wearer was treated for bilateral Acanthamoeba keratitis and underwent penetrating keratoplasty in the right eye for descemetocele with impending risk of perforation. The postoperative course was uneventful and topical steroids were combined with neomycin and propamidine. Two months after the operation in the right eye the patient presented with active infection in the left eye. One month later recurrence appeared in the right eye, as a central corneal infiltrate in the graft. RESULTS: Recurrences in both eyes were successfully treated with a combination of hexamidine and neomycin, and with polyhexamethylene biguanide respectively. The right eye was regrafted three months after the recurrence and penetrating keratoplasty was done two years later in the left eye. Both grafts were successful and remained clear. There has been no further recurrence in the long-term follow-up. CONCLUSIONS: Recurrence of Acanthamoeba keratitis after penetrating keratoplasty a chaud may occur even several months after the operation and the manifestation may be atypical. Current antiamoebal therapy was effective and regrafting in the quiet eye was successful.

Acanthamoeba↗

PubMed1997

[Laser therapy of age-related exudative macular degeneration].

Aim of the study is to determine the percent of cases with exsudative form of age related macular degeneration that are eligible for treatment by the Macular Photocoagulation Study guidelines after initial visit. Authors also evaluated efficacy of focal laser treatment in visual acuity. In a group of 80 eyes in 55 patients only in 13 (16%) eyes was found classic choroidal neovascular membrane and 12 (15%) of them met eligibility criteria for treatment by the MPS criteria. 6 CNV (46%) were treated with argon-green laser according to MPS photocoagulation criteria. Visual acuity of treated eyes was improved in 2 eyes, unchanged in 1 eye and worsened in 3 eyes. For worse visual outcomes were responsible recurrent CNV which occurred in 3 (50%) of treated eyes.

Aged↗

PubMedDate not supplied

Nocardia keratitis: a case report.

PURPOSE: To describe a case of Nocardia keratitis resistant to 2% amikacin, with a toxic-allergic reaction to fortified topical 5% amikacin, and recurrence of the infection with topical corticosteroids. METHODS: Nocardia was diagnosed from a smear and positive culture and identified as Nocardia asteroides by gas chromatography and quantitative fatty acid analysis using the Microbial Identification System. Treatment was started with topical 2% amikacin, which was subsequently raised to 5% because of clinical resistance. RESULTS: A toxic-allergic reaction was observed after 5% amikacin so the drug was discontinued and commercially available drugs combining 1% chloramphenicol, 0.5% tetracycline, and 18 mil IU colistin with 0.3% ofloxacin were given. These were well tolerated and the infection improved quickly. After 1 month the antibiotics were discontinued and topical 0.1% clobetasone was given to reduce scar formation. The infection recurred after 1 week but responded to 3 months of the previous antibiotic combination and its sensitivity was checked with the Epsilometer test. CONCLUSIONS: Nocardia keratitis may not respond to 2% topical amikacin and fortified topical 5% amikacin may cause a strong toxic-allergic reaction. A commercially available combination of chloramphenicol, tetracycline, and colistin, with ofloxacin, may be effective but the treatment must be continued for several months. Topical steroids should only be used with considerable caution since they can lead to relapse of the infection.

Adult↗